- Home
- TSHA vs FIGS Comparison
TSHA vs FIGS Comparison
Compare TSHA & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- FIGS
- Stock Information
- Founded
- TSHA 2019
- FIGS 2013
- Country
- TSHA United States
- FIGS United States
- Employees
- TSHA N/A
- FIGS N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- FIGS Apparel
- Sector
- TSHA Health Care
- FIGS Consumer Discretionary
- Exchange
- TSHA Nasdaq
- FIGS Nasdaq
- Market Cap
- TSHA 1.2B
- FIGS 1.2B
- IPO Year
- TSHA 2020
- FIGS 2021
- Fundamental
- Price
- TSHA $4.87
- FIGS $9.82
- Analyst Decision
- TSHA Strong Buy
- FIGS Hold
- Analyst Count
- TSHA 9
- FIGS 5
- Target Price
- TSHA $10.22
- FIGS $8.60
- AVG Volume (30 Days)
- TSHA 3.9M
- FIGS 2.8M
- Earning Date
- TSHA 11-04-2025
- FIGS 11-06-2025
- Dividend Yield
- TSHA N/A
- FIGS N/A
- EPS Growth
- TSHA N/A
- FIGS 91.65
- EPS
- TSHA N/A
- FIGS 0.11
- Revenue
- TSHA $6,310,000.00
- FIGS $581,034,000.00
- Revenue This Year
- TSHA N/A
- FIGS $4.73
- Revenue Next Year
- TSHA N/A
- FIGS $3.67
- P/E Ratio
- TSHA N/A
- FIGS $92.37
- Revenue Growth
- TSHA N/A
- FIGS 5.90
- 52 Week Low
- TSHA $1.05
- FIGS $3.57
- 52 Week High
- TSHA $5.51
- FIGS $10.24
- Technical
- Relative Strength Index (RSI)
- TSHA 62.34
- FIGS 67.74
- Support Level
- TSHA $3.92
- FIGS $9.46
- Resistance Level
- TSHA $4.34
- FIGS $9.83
- Average True Range (ATR)
- TSHA 0.30
- FIGS 0.52
- MACD
- TSHA 0.06
- FIGS 0.04
- Stochastic Oscillator
- TSHA 98.33
- FIGS 81.04
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About FIGS FIGS Inc.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.